Published in Free Radic Biol Med on June 09, 2012
Oxidative stress and Parkinson's disease. Front Neuroanat (2015) 1.08
The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Metallomics (2014) 0.89
Proteomics of muscle chronological ageing in post-menopausal women. BMC Genomics (2014) 0.86
Oxidative stress mechanisms underlying Parkinson's disease-associated neurodegeneration in C. elegans. Int J Mol Sci (2013) 0.85
Parkinson's disease and enhanced inflammatory response. Exp Biol Med (Maywood) (2015) 0.79
DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating Pink1. Biochem J (2015) 0.78
Mitochondrial control of cell bioenergetics in Parkinson's disease. Free Radic Biol Med (2016) 0.78
DJ1 analysis in a large cohort of Italian early onset Parkinson Disease patients. Neurosci Lett (2013) 0.77
Neurotransmitter CART as a New Therapeutic Candidate for Parkinson's Disease. Pharmaceuticals (Basel) (2013) 0.76
Life-time expression of the proteins peroxiredoxin, beta-synuclein, PARK7/DJ-1, and stathmin in the primary visual and primary somatosensory cortices in rats. Front Neuroanat (2015) 0.75
DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine. Front Microbiol (2015) 0.75
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science (2011) 3.52
Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol (2012) 2.32
Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med (2008) 1.83
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain (2012) 1.82
Macrophages and neurodegeneration. Brain Res Brain Res Rev (2005) 1.64
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J (2007) 1.63
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation (2013) 1.59
Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J Neurochem (2006) 1.43
Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta (2010) 1.40
The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett (2011) 1.39
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain (2008) 1.38
Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J (2006) 1.34
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion (2010) 1.34
Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med (2004) 1.34
The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol (2003) 1.32
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol (2006) 1.30
Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol (2009) 1.29
Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal (2011) 1.29
Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology (2007) 1.28
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol (2012) 1.22
Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab (2003) 1.21
The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol (2007) 1.20
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol (2005) 1.20
Retinoic acid induces blood-brain barrier development. J Neurosci (2013) 1.17
RhoA activation promotes transendothelial migration of monocytes via ROCK. J Leukoc Biol (2003) 1.16
Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation. Epilepsia (2012) 1.15
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis (2005) 1.14
Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol (2003) 1.14
(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) (2007) 1.14
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation (2012) 1.09
MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. J Neurosci (2013) 1.07
Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol (2009) 1.07
MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO. J Cereb Blood Flow Metab (2007) 1.07
SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am J Physiol Heart Circ Physiol (2007) 1.05
CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients. J Autoimmun (2011) 1.05
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev (2007) 1.04
Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Ann Neurol (2013) 1.04
Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J Neuropathol Exp Neurol (2005) 1.03
Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol Dis (2006) 1.02
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med (2010) 1.00
Functions of lipid raft membrane microdomains at the blood-brain barrier. J Mol Med (Berl) (2009) 0.99
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol (2008) 0.99
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin. Acta Neuropathol (2014) 0.99
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol (2012) 0.98
Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol (2008) 0.97
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation. J Neuroinflammation (2014) 0.97
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog Neurobiol (2012) 0.97
Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain. Brain Pathol (2008) 0.96
Tumor infiltrating macrophages reduce development of peritoneal colorectal carcinoma metastases. Cancer Lett (2008) 0.95
Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol (2009) 0.95
Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J Immunol (2008) 0.95
Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J (2012) 0.95
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol (2012) 0.95
Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior. J Neurosci (2011) 0.94
Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. CNS Neurol Disord Drug Targets (2011) 0.93
Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem Pharmacol (2003) 0.93
Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients. Acta Neuropathol Commun (2014) 0.92
Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Arch Toxicol (2014) 0.92
The extracellular matrix in multiple sclerosis pathology. J Neurochem (2007) 0.91
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation (2012) 0.91
Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol (2011) 0.91
Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions. Neurobiol Dis (2009) 0.91
Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain. Brain Pathol (2010) 0.90
T lymphocytes impair P-glycoprotein function during neuroinflammation. J Autoimmun (2009) 0.90
NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. Free Radic Biol Med (2006) 0.90
P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One (2009) 0.90
Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining. Gut (2011) 0.90
Brain endothelial barrier passage by monocytes is controlled by the endothelin system. J Neurochem (2011) 0.89
Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp Gerontol (2007) 0.89
The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radic Res (2002) 0.89
Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis. NMR Biomed (2010) 0.89
Characteristics of dyshoric capillary cerebral amyloid angiopathy. J Neuropathol Exp Neurol (2010) 0.89
Tissue transglutaminase modulates alpha-synuclein oligomerization. Protein Sci (2008) 0.88
The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J Neurochem (2010) 0.88
Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Neurodegener Dis (2012) 0.87
Protective effects of peroxiredoxin-1 at the injured blood-brain barrier. Free Radic Biol Med (2008) 0.87